[The importance of changes in whole-body balance of sodium and noradrenaline in essential hypertension (author's transl)]
- PMID: 30856
- DOI: 10.1007/BF01477131
[The importance of changes in whole-body balance of sodium and noradrenaline in essential hypertension (author's transl)]
Abstract
In 22 patients with essential hypertension plasma levels and urine excretions of sodium and noradrenaline were studied before, during and after long-term beta-blockade with pindolol. The relation between mean blood pressure and the quotient of sodium-/noradrenaline-excretion changed during treatment (placebo r=-0.34; pindolol r=+0.31). During placebo there existed a significant (p is less than 0.03) correlation between blood pressure and sodium-excretion which disappeared during beta-blockade. No correlation between blood pressure and noradrenaline was seen during placebo, whereas during beta-blockade a significant (p is less than 0.003) correlation was observed. In contrast to the placebo period there was a significant positive correlation between sodium- and noradrenaline-excretion during long-term treatment with pindolol. It is concluded that whole-body balance of sodium and noradrenaline is an important factor in essential hypertension.
Similar articles
-
Balance of noradrenaline and sodium during chronic beta-receptor blockade in patients with essential hypertension.Arch Int Pharmacodyn Ther. 1980;Suppl:67-75. Arch Int Pharmacodyn Ther. 1980. PMID: 6106459
-
[Interrelations between blood pressure, blood volume, plasma renin and urinary catecholamines during beta-blockade in essential hypertension (author's transl)].Klin Wochenschr. 1976 Aug 15;54(16):765-73. doi: 10.1007/BF01614293. Klin Wochenschr. 1976. PMID: 8663 Clinical Trial. German.
-
[Effect of chronic beta-adrenergic blockade on blood pressure and release of renin, aldosterone and cortisol in essential hypertension (author's transl)].Klin Wochenschr. 1975 Oct 1;53(19):907-11. doi: 10.1007/BF01468983. Klin Wochenschr. 1975. PMID: 241876 Clinical Trial. German.
-
The effect of prindolol on plasma noradrenaline, plasma renin and sodium-potassium metabolism in patients with essential hypertension.Adv Clin Pharmacol. 1976;11:66-9. Adv Clin Pharmacol. 1976. PMID: 1032572
-
Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.Postgrad Med J. 1983;59 Suppl 3(689):140-58. Postgrad Med J. 1983. PMID: 6139800 Free PMC article. Review.
Cited by
-
How intrinsic sympathomimetic activity modulates the haemodynamic responses to beta-adrenoceptor antagonists. A clue to the nature of their antihypertensive mechanism.Br J Clin Pharmacol. 1982;13(Suppl 2):245S-257S. doi: 10.1111/j.1365-2125.1982.tb01922.x. Br J Clin Pharmacol. 1982. PMID: 6125175 Free PMC article.